Factors Affecting Health-Related Quality of Life and Physical Activity after Liver Transplantation for Autoimmune and Nonautoimmune Liver Diseases: A Prospective, Single Centre Study

Table 1

Demographic and clinical data on analyzed patients.

Total number of patients	𝑛=107
Age at transplantation [years, mean ± SD (range)]	46.7 ± 11.6 (17–63)
Age at survey [years, mean ± SD (range)]	49.9 ± 11.4 (21–67)
Gender [male/female]	62 (57.9%)/45 (42.1%)
BMI [kg/m^2, mean ± SD (range)]	27.0 ± 5.0 (18.0–43.0)
Period after transplantation
Group-A (6–12 months)	21 (19.6%)
Group-B (13–36 months)	48 (44.9%)
Group-C ( >36 months)	38 (35.5%)
Employment (yes/no)	40 (37.4%)/67 (62.6%)
Original diagnosis
Alcohol liver disease	24 (22.4%)
Viral hepatitides	15 (14.0%)
Autoimmune hepatitis	10 (9.4%)
Autoimmune cholestatic (PBC, PSC)	23 (21.5%)
Other*	35 (32.7%)

Group-A: 6 months to 12 months after liver transplantation; group-B: from 12 months to 36 months after liver transplantation; group-C: over 36 months after liver transplantation;   ∗other reasons for LTx included cryptogenic cirrhosis (𝑛=8); Fulminant Wilson’s (𝑛=5), chronic Wilson’s (𝑛=2); non-A, non-B hepatitis (𝑛=7); amanita poisoning (𝑛=7); Budd-Chiari syndrome (𝑛=4); secondary biliary cirrhosis (𝑛=1) and acute fatty liver of pregnancy (𝑛=1). BMI: body mass index; PBC: primary biliary cirrhosis; PSC: primary sclerosing cholangitis.